Impact of Biosimilars in Ophthalmology

Expert retina specialists review the impact of biosimilars in clinical ophthalmology practice, highlighting the potential decrease of financial burden to the patient.

Related Keywords

Michaela Klufas , ,Biosimiliars ,Ophthalmology ,Wet Amd ,Age Related Macular Edema ,Off Label Bevacizumab ,Compounded Medications ,Reduced Clinical Efficacy ,